મેટ્રિક્સ
 
 
Moneycontrol.com ભારત | ઓડિટર રિપોર્ટ > Finance - Investments > ઓડિટર રિપોર્ટ થી ડેઝલ કન્ફૈન્ડિવ - બીએસઈ: 531270, ઍનઍસઈ : N.A

ડેઝલ કન્ફૈન્ડિવ

બીએસઈ: 531270  |  ઍનઍસઈ : N.A  |  ISIN: INE149E01027  |  Finance - Investments

શોધો ડેઝલ કન્ફૈન્ડિવ કનેક્શન � Mar 12
ઓડિટર રિપોર્ટ વર્ષાન્ત : Mar '13
We have audited the attached Balance Sheet of DAZZEL CONFINDIVE Ltd.,
 as at 31st March, 2013 and the annexed Profit and Loss Account and cash
 flow statement for the year ended on that date. These financial
 statements are the responsibility of the Company''s Management. Our
 responsibility is to express an opinion on these financial statements
 bases on our audit.
 
 We conducted our audit in accordance with auditing standards generally
 accepted in India, Those standard require that we plan and perform the
 audit to obtain reasonable assurance about whether the financial
 statements are free of material misstatement. An audit includes
 examining, on a test basis, evidence supporting the amounts and
 disclosures in the financial statements. An audit also includes
 assessing the accounting principles used and significant estimates made
 by the management, as well as evaluating the overall financial
 statement presentation. We believe that our audit provides a reasonable
 basis for our opinion.
 
 As required by the Companies (Auditor''s Report) Order 2003 issued by
 the central Government of India in terms of section 227 (4A) of the
 Companies Act, 1956 we enclose in the Annexure a statement on the
 matters specified in paragraphs 4 and 5 of the said order.
 
 Further to our comments in the Annexure referred to above, we report
 that:
 
 (a) We have obtained all the information and explanations, which to the
 best of our knowledge and belief were necessary for the purpose of our
 audit.
 
 (b) In our opinion proper books of accounts as required by law have
 been kept by the Company so far as appears from our examination of such
 books.
 
 (c) The Balance Sheet and the Profit & Loss Account referred to in this
 report are in agreement with the books of account.
 
 (d) In our opinion and to the best of our information the said Balance
 Sheet and Profit & Loss Account and cash flow statement comply with the
 Accounting standard referred to in section 211(3c) of the companies
 act, 1956.
 
 (e) On the basis of written representations received from the
 directors, as on 31st, March, 2013 and taken on record by the Board of
 Directors, we report that none of the directors is disqualified as on
 31st March, 2013 from being appointed as a director in terms of clause
 (g) of sub-section (1) of section 274 of Companies Act, 1956.
 
 (f) In our opinion and to the best of our information and according to
 the explanations given to us, the said accounts give the information
 required by the Companies Act, 1956, in the manner so required and
 gives a true and fair view in conformity with the accounting principles
 generally accepted in India:- i.  In so far as it relates to the
 Balance Sheet, of the state of affairs of the Company as at 31st March,
 2013 and ii.  In so far as it relates to the Profit & Loss Account of
 the profit / (loss) of the company for the year ended on that date.
 iii.  In the case of the cash flow statement, of the cash flow for the
 year ended on that date.
 
 Referred in paragraph 3 of our report of even date.
 
 i) The Company has maintained proper records to show full particulars
 including quantitative details and situation of fixed assets. We are
 informed that, the fixed assets other than the assets let on lease,
 have been physically verified by the management at reasonable intervals
 during the year and no material discrepancies between the book records
 and physical inventory have been noticed on such verification.
 
 ii) Note of fixed assets of the company have been revalued during the
 year.
 
 iii) In our opinion and according to the information and explanations
 given to us, the procedure of physical verification of inventory
 followed by the management reasonable and adequate in relation to the
 size of the company and the nature of its business.
 
 iv) No material discrepancy have been noticed between the physical
 stocks, as verified and book records.
 
 v) In our opinion on the basis of our examination of the stock record,
 the valuation of stock is fair and proper in Accordance with the
 normally accepted accounting principals.
 
 vi) The company has not taken any loans from companies, firms or other
 parties listed in registers maintained u/s. 301 of the Co. Act , 1956,
 except Fixed deposit. The rate of interest and other terms and
 conditions are in our opinion prima-facie non prejudicial to the
 interest of the Companies under the same management as defined u/s.
 (1B) of section 370 of the said Act.
 
 vii) The company has not granted or taken any loans, secured or
 unsecured to /from companies, firms or other parties covered in the
 register maintained u/s. 301 of the Act.
 
 viii) The company has not given any loans or advances in the nature of
 loans to the companies under the same management as defined under
 subsection (1B) of section 370 of the Companies Act 1956.
 
 ix) In our opinion and according to information and explanations given
 to us, there are adequate internal control procedures commensurate with
 the size of the Company and the nature of its business for purchase of
 inventory (Shares & Securities).
 
 x) On the basis of information and explanation given to us, in respect
 of transactions entered into for purchase and sale of shares and
 securities and services rendered with the parties whose name are
 entered in the registered maintained under section 301 of the companies
 act, 1956 and aggregating during the year to Rs. 50,000 /- or more, we
 are of the opinion that the transactions are made at prices which are
 reasonable having regards to prevailing market price.
 
 xi) In our opinion and according to the information and explanation
 given to us, with regards to the deposits accepted from public the
 company has complied with direction issued by the Reserve Bank of India
 and the provisions of section 58A of the Companies Act, 1956.
 
 xii) The company does not have any formal system of internal audit.
 However in our opinion according to information and explanation given
 to us, the internal control procedures are adequate, considering the
 size and nature of business of the Company.
 
 xiii) The provision of the section 209(1) (d) of the Companies Act,
 1956 regarding the maintenance of the cost records are not applicable.
 
 xiv) As informed to us the provision of Provident Fund Act and
 employees state Insurance Act are not applicable to the company.
 
 xv) According to the Information and explanation given to us no
 undisputed amounts is respect of Income-tax, Wealth Tax, Sales Tax,
 Custody Duty and Excise duty were outstanding as at 31st March 2013 for
 a period of more than six months from the date day become payable.
 
 xvi) According to the information and explanation given to us and based
 on the generally accept audit procedure carried out by us no personal
 expenses of employees or directors have been charged to Revenue
 Account, Other that those payable under contractual obligations or in
 accordance with generally accepted business practice.
 
 xvii) In relation to the service activities of the company there exists
 a reasonable internal control system commensurate with the size of the
 company and nature of its business.
 
 xviii) In our opinion and on the basis of information and explanation
 given to us, the services rendered by the company do not require my
 allocation of men hours.
 
 xix) The company has not granted any loans and advances on the basis of
 securities by way of pledge of shares, debentures and other securities.
 
 xx) The provision of any special statue applicable to chit funds, nidhi
 or mutual benefit society do not apply to the company.
 
 xxi) The company has maintained proper records of transactions in
 respect of trading in shares and other securities and timely entries
 have been made therein. All shares, debentures and other securities
 held by the company in its own name accept to the extent exemption
 granted u/s. 49 of the companies act, 1956 or in respect of certain
 investments which are either locked for transfer or held with valid
 transfer deed.
 
 xxii) In our opinion clause (xii), (xiv) and (xx) or para (a) of the
 aforesaid Order are not applicable to the company for the year under
 review.
 
 xxiii) The company has not made any preferential allotment on shares to
 parties and companies covered in the register maintained u/s. 301 of
 the Co. Act.
 
 xxiv) The Company has not raised any money by public issue during the
 year.
 
 xxv) During the year the company has not issued any debenture.
 
 xxvi) In respect of company''s trading in equity activity, we are
 informed that there are no damaged stocks lying with the company.
 
 xxvii) According to the information and explanation given to us, no
 fraud on or by the company has been noticed or reported during the
 year.
 
 PLACE : JAORA(MP)                For NAHAR V. & COMPANY
 
 DATE : 16/05/2013                CHARTERED ACCOUNTANTS
 
                                  Sd/- 
 
                                  VISHAL NAHAR PROPRIETOR
 
                                  Membership no. : 400217
સ્તોત્ર: રેલીગેર ટેકનોવા


ન્યૂઝ ફ્લૅશ

  • સન ફાર્મા અમેરિકામાં Imatinib Mesylate લોન્ચ
  • કારોબાર : શૅર્સ સંબધિત પ્રશ્નો પૂછવા માટે BH (SPACE) STOCK સાથે તમારું નામ અને ફોન નંબર લખીને મેસેજ કરો 51818 પર
  • કારોબાર : BH (SPACE) આપના સ્ટોકની વિગત, સાથે જ આપનું નામ લખી 51818 પર મેસેજ કરો અને અમારા ટોલ ફ્રી નંબર 1800-4190-709 પર કાૅલ કરો અને જવાબ મેળવો અમારા ખાસ શાૅ બજાર હેલ્પલાઇનમાં સોમવારથી શુક્રવાર સવારે 11.30 કલાકે
  • કારોબાર : પર્સનલ ફાઇનાન્સને લગતા તમારા કોઈ પ્રશ્ન હોય તો તમે અમને money@network18online.com પર મોકલી શકો છો. તમારા સવાલના જવાબ મની મૅનેજરમાં આપવામાં આવશે
  • કારોબાર : ચીનના આર્થિક આંકડાઓ જાન્યુઆરી Caixin ફાઈનલ મેન્યુફેક્ચરીંગ PMI 48.2 થી વધી 48.4 (MoM)
  • કારોબાર : US FDAની મંજૂરી મળી ઓરોબિન્દો ફાર્માને ડાયાબિટિશની દવા Saxagliptin માટે મંજૂરી મળી
  • કારોબાર : US FDAની મંજૂરી મળી ડો.રેડ્ડીઝને બેક્ટેરિયલ ઈન્ફેક્શનની દવા ડોક્સીસાયક્લીન માટે મંજૂરી મળી
  • કારોબાર : US FDAની મંજૂરી મળી માઈગ્રેનની દવા Sumatriptan માટે ડો.રેડ્ડીઝને મંજૂરી મળી
  • કારોબાર : જાપાનના આર્થિક આંકડાઓ જાન્યુઆરીમાં મેન્યુફેક્ચરીંગ PMI 52.6 થી ઘટી 52.3 (MoM)
  • કારોબાર : વકરાંગીએ ટાટા AIG જનરલ ઈન્શ્યોરન્સ કંપની સાથે કરાર કર્યા